Shama Mahendru
New Delhi, DL, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Magnitude and Determinants of Weight Loss Response to GLP-1/GIP Receptor Agonists in India: A Real-World Time-to-Event Analysis.
Journal: Indian journal of endocrinology and metabolism
Published: December 31, 2025
Effectiveness of Oral Semaglutide in Management of Type 2 Diabetes: A Real-World Study from India.
Journal: Indian journal of endocrinology and metabolism
Published: July 15, 2024
Low FT3 is an independent marker of disease severity in patients hospitalized for COVID-19.
Journal: Endocrine connections
Published: September 22, 2021
Video Consultation Versus In-Person Clinic Visit for Glycemic Control in Type 2 Diabetes during COVID-19 Pandemic (VIP-CD Study).
Journal: Indian journal of endocrinology and metabolism
Published: August 04, 2021
Lack of association of baseline 25-hydroxyvitamin D levels with disease severity and mortality in Indian patients hospitalized for COVID-19.
Journal: Scientific reports
Published: December 15, 2020
High prevalence of diabetes and other comorbidities in hospitalized patients with COVID-19 in Delhi, India, and their association with outcomes.
Journal: Diabetes & metabolic syndrome
Published: December 08, 2020
Adverse Effect Profile and Effectiveness of Sodium Glucose Co-transporter 2 Inhibitors (SGLT2i) - A Prospective Real-world Setting Study.
Journal: Indian journal of endocrinology and metabolism
Published: April 25, 2019
Long-term efficacy of liraglutide in Indian patients with Type 2 diabetes in a real-world setting.
Journal: Indian journal of endocrinology and metabolism
Published: October 13, 2016
Usage of pioglitazone at Medanta, the Medicity.
Journal: Indian journal of endocrinology and metabolism
Published: April 05, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026